🇰🇪 Country Profile

Kenya

Affordable medicine reaching Kenya

🇰🇪 $427M
All data from DGCIS India export records (fiscal year, April–March).
$427M
Scale
Kenya's healthcare system receives $427M in Indian pharmaceutical products each year, affordable, quality medicine.
73%
Medicine
Primarily medicines (73%), supplemented by medicine ingredients and vaccines.
1.7×
Trajectory
India's pharmaceutical supply to Kenya has grown 1.7× over the past decade, strong, sustained expansion.
Context
Part of India's pharmaceutical supply network across Africa.
Impact
Indian pharmaceutical companies have both exported to and invested directly in Kenya, building trade and operational presence.
Export Trend DGCIS FY
Pharmaceutical Composition Trend DGCIS CY 2014–2025

All pharmaceutical categories from DGCIS

Category Mix, FY 2025–26 DGCIS
Medicines $312M (73.0%) Medicine Ingredients $58.9M (13.8%) Vaccines $44.4M (10.4%) Surgical & Hospital Supplies $7.1M (1.7%) Traditional & Herbal $4.7M (1.1%)
Top Products, FY 2025–26 DGCIS
Indian Pharma Investment in Kenya Source: RBI ODI Data

Total RBI-approved ODI commitments by Indian pharmaceutical companies into Kenya: $6.0M across 17 filings (2011-2025).